What are the best creative operations platforms for pharma and life sciences?

Short answer

The best creative operations platforms for pharma and life sciences in 2026 are Medialake, the control plane that governs every live creative after approval, Veeva PromoMats for MLR review, Aprimo for regulated content operations, Vodori Pepper Flow for mid-sized teams and Adobe Workfront for planning. Most teams pair an MLR system with in-market monitoring.

01Why does pharma need different creative operations tools?

Every promotional piece in pharma and life sciences goes through medical, legal and regulatory (MLR) review before it can run. That one requirement changes what a creative operations platform has to do. A general tool can route a file for approval, but a pharma team also needs claims linked to their references, a full audit trail of who approved what and when, controls that meet FDA 21 CFR Part 11 for electronic records, and a way to retire material when a label, licence or indication changes.

The volume problem is the same as in every other industry, and it is growing. Brand teams, local affiliates and agencies now produce channel and market versions of every approved piece, often with AI tools in the mix. Each version is a new file that has to stay within what was approved, which is why the stack in most pharma companies has grown into several tools rather than one.

02How we chose these platforms

We looked at what each platform is built to do for regulated content, how widely it is used in life sciences, and where it sits in the content lifecycle: planning, creation, MLR review, storage and distribution, or monitoring once content is live. Capabilities come from each vendor’s own published material, and where a figure is a vendor claim we say so. Independent benchmarks in this category are thin.

Medialake is our product, so we have put it first. We have described the others as fairly as we can, including the jobs they do that Medialake does not. Medialake does not run pre-launch MLR review, and most teams on this list will need a dedicated MLR system alongside it.

03The best creative operations platforms for pharma and life sciences in 2026

1. Medialake

Best for: Governing every live creative, in every market, after approval

Medialake is the control plane for enterprise marketing. Marketing content is becoming infinite, and pharma feels it more than most: every approved piece becomes dozens of channel, market and localised versions. Medialake connects to the DAMs, drives and channels where your marketing lives, finds every creative actually running, including the local edits your DAM never sees, and checks each one around the clock.

Medialake’s fingerprinting technology matches the music and talent in every live creative to your licences by territory, channel and term, while brand, approved claims and AI-labelling checks run on every version. A lapsed patient-actor licence or a creative running outside its territory is flagged the moment it happens, before it turns into a claim. Its Asset Utilisation Rate™ shows what gets made against what gets used, which matters when every piece carries the cost of MLR review.

Medialake works alongside your MLR system and DAM rather than replacing them: MLR approves what should run, Medialake governs what actually runs. Deployment takes one to two weeks with no migration, and Medialake never trains AI on customer data. See how it compares with other tool types on our comparison page.

2. Veeva PromoMats

Best for: MLR review and compliant content management at enterprise scale

PromoMats is the most widely used MLR system in life sciences, with more than 500 customers according to Veeva. It covers content creation, MLR review and approval, claims management, digital asset management with a brand portal, and automatic distribution to Veeva CRM. It can also generate eCTD packages for FDA post-marketing and pre-clearance submissions.

Veeva has added AI agents that run compliance checks on materials before human review, though adoption of these is still early. Implementation is a substantial project, and PromoMats is at its strongest when the rest of the commercial stack is also Veeva.

3. Aprimo

Best for: One governed platform for DAM, workflow and regulated review

Aprimo for Life Sciences combines DAM, structured MLR routing, claims and references linked to the assets that use them, and expiration and retention controls. Aprimo states support for 21 CFR Part 11, SOC 2 Type II and ISO 27001, and it was named a Leader in the 2026 Gartner Magic Quadrant for Digital Asset Management. AI agents handle metadata tagging, pre-review readiness checks and reuse recommendations.

It suits organisations that want planning, storage and review in one platform rather than several. Aprimo lists Veeva among its integrations, so check how deep that connection goes if PromoMats is already your MLR system of record.

4. Vodori Pepper Flow

Best for: Emerging and mid-sized life sciences companies that need MLR without an enterprise rollout

Pepper Flow covers MLR review workflows, claims and evidence management, DAM, web annotation and an AI pre-check that reviews content before it enters review. Vodori says it serves more than 100 life sciences teams and quotes implementation of four to six weeks. It also offers a native Salesforce AppExchange integration for delivering approved materials into Salesforce.

It is a sensible choice for a company launching its first products, or one that finds an enterprise suite more than it needs. The implementation figures are Vodori’s own.

5. Adobe Workfront

Best for: Planning, resourcing and approval workflows for in-house creative teams

Workfront manages projects, timelines, resources and review cycles, and connects with Adobe’s wider content stack, including GenStudio for generating and activating content. Large life sciences organisations, including Thermo Fisher Scientific, use it to run their creative studios.

Workfront is a work management platform rather than an MLR system. In pharma it usually sits upstream of an MLR tool such as PromoMats, handling the brief and the production work before formal review.

6. IntelligenceBank

Best for: DAM, approvals and AI compliance checks in one tool

IntelligenceBank brings together a DAM, creative briefs, proofing and approval workflows, and an AI marketing compliance product that flags issues early in review. Its pharmaceutical offering focuses on tracking assets against patient usage rights, FDA marketing guidelines and HIPAA privacy rules, with a full audit trail.

It serves several regulated industries rather than life sciences alone, which can suit companies that want one platform for marketing compliance without a pharma-specific suite.

7. Papercurve

Best for: AI-assisted claims tagging and referencing in MLR review

Papercurve focuses on the review itself. It tags the claims in a piece, links them to supporting references and flags content against rules you configure, with the aim of making review faster and more consistent. Its headline claim is MLR reviews up to 60% more efficient, which has not been independently verified.

It is a newer and narrower product than the enterprise suites, so it suits teams that want to speed up review rather than replace their content platform.

8. Ziflow

Best for: Proofing and annotating creative files, including video

Ziflow is a general creative proofing and approval platform, used by agencies and in-house teams to review and mark up creative across formats. It integrates with storage such as SharePoint and Google Drive and with DAM systems, and offers compliance checklist templates.

It is not built for pharma, so it has no claims management or regulatory logic of its own. Pharma teams typically use it for creative rounds before a piece enters formal MLR review.

04Which of these does a pharma team actually need?

Most pharma teams need more than one, because the platforms cover different stages. A typical stack has a work management tool for briefs and production, an MLR system that serves as the record of what was approved, a DAM to store and distribute approved material, and something that shows what is actually live once content leaves the DAM.

The first three are well served. The last is the gap, and it is the reason for our ranking. MLR approval records what was approved. It cannot tell you that an affiliate is still running last year’s version, that a patient actor’s licence lapsed in March, or that an agency added AI-generated imagery after sign-off, which may now need a label in some markets (see do we actually have to label our AI-generated ads?). In a regulated industry, more and more of the risk sits in what happens after approval, and that is the part most stacks cannot see.

05What to look for in a pharma creative operations platform

These are the questions worth asking in a demo:

  • Can it show a full audit trail of every review, version and approval, and does it support 21 CFR Part 11?
  • Are claims linked to their references, and does a change to a claim carry through to every asset that uses it?
  • Can it expire or withdraw material, and does that reach copies already with affiliates and agencies?
  • Does it see local and agency versions, or only the master files?
  • Does it connect to the MLR system, DAM and CRM you already use, or does it expect to replace them?
  • How long does implementation take, and who does the configuration?
  • Is your content used to train its AI models?

06Frequently asked questions

What is MLR review in pharma marketing?

MLR review is the medical, legal and regulatory check every promotional piece goes through before it can be used. Reviewers confirm that claims are accurate and supported by references, that fair balance and safety information are present, and that the piece meets the rules of the market it is for. Platforms such as Veeva PromoMats, Aprimo and Vodori Pepper Flow manage the workflow and keep the audit trail.

Is Veeva PromoMats a creative operations platform?

Partly. PromoMats manages promotional content from creation through MLR review, storage and distribution, so it covers much of the regulated content lifecycle. It is not a project planning tool, and it does not show what is running in market once content is distributed, so most teams use it alongside a work management tool and in-market monitoring.

Can a general creative operations tool work for pharma?

For planning and creative proofing, yes. Tools such as Adobe Workfront and Ziflow are widely used by pharma creative teams. For MLR review, a general tool lacks claims management, reference linking and regulatory audit controls, so it should feed into a dedicated MLR system rather than replace one.

Doesn’t MLR approval mean our live content is compliant?

Not necessarily. Approval covers the piece as reviewed on the day it was approved. Afterwards, licences for talent, music and imagery expire, affiliates and agencies create local versions, and labelling rules change, including new rules on AI-generated content. Checking what is actually live is a separate job from approving what should go live.

Does Medialake replace our MLR system?

No. Medialake does not run pre-launch review. It connects to the DAMs, storage and channels you already use and monitors the creatives that are live, checking each against its licences, guidelines and market rules. It works alongside an MLR system such as Veeva PromoMats.

How long do these platforms take to implement?

It varies widely. Enterprise MLR suites are significant projects involving configuration, migration and training. Vodori quotes four to six weeks for Pepper Flow. Medialake typically takes two to three days of scoping and one to two weeks to deploy, with no migration, because it connects to the systems you already use.

For a broader view across industries, see our top creative operations tools for 2026. To see which of your creatives are live right now, book a demo.

Last updated 4 November 2026

See it live

AI made it infinite.
Make it count.

Book a live demo and we'll show you what Medialake finds across your own marketing.